SCHEMBL20248905

SCHEMBL20248905

c1ccc(-c2c3cc(-c4ccc(-c5nnc(-c6ccc(-c7cc8c(-c9ccccc9)c9sccc9c(-c9ccccc9)c8s7)cc6)n5-c5ccccc5)cc4)sc3c(-c3ccccc3)c3ccsc23)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 6/20 0.44
▸ HSD17B10 Q99714 5/20 0.44
▸ AVPR1A P37288 1/20 0.42
▸ SMN1; SMN2 Q16637 3/20 0.40
▸ HPGD P15428 2/20 0.40
▸ ALDH1A1 P00352 5/20 0.39
▸ TSHR P16473 2/20 0.39
▸ GLA P06280 1/20 0.36
▸ POLB P06746 3/20 0.36
▸ LMNA P02545 2/20 0.36
▸ RXFP1 Q9HBX9 2/20 0.36
▸ OPRD1 P41143 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ MEN1 O00255 4/20 0.35
▸ KMT2A Q03164 3/20 0.35
▸ MAPK1 P28482 1/20 0.35
▸ CYP1A2 P05177 1/20 0.35
▸ CYP3A4 P08684 1/20 0.35
▸ CYP2D6 P10635 1/20 0.35
▸ CYP2C9 P11712 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20248890 0.85 ESR2 (0.46) KDM4ESMN1; SMN2HPGDALDH1A1POLB
SCHEMBL20248872 0.80 ADORA2A (0.46) KDM4ESMN1; SMN2HPGDALDH1A1GLA
SCHEMBL20248893 0.79 ESR2 (0.43) KDM4ESMN1; SMN2HPGDALDH1A1POLB
SCHEMBL20248904 0.79 NPC1 (0.44) KDM4EHSD17B10SMN1; SMN2HPGDALDH1A1
SCHEMBL20248873 0.79 ADORA2A (0.45) KDM4ESMN1; SMN2HPGDALDH1A1GLA
SCHEMBL20248901 0.77 MEN1 (0.43) KDM4EHPGDALDH1A1GLALMNA
SCHEMBL20248908 0.76 ADORA1 (0.43) KDM4EHPGDALDH1A1POLBLMNA
SCHEMBL20248869 0.76 ADORA2A (0.42) KDM4ESMN1; SMN2HPGDALDH1A1GLA
SCHEMBL20248879 0.75 PTP4A3 (0.39) POLB
SCHEMBL20248903 0.75 ADORA1 (0.45) HSD17B10ALDH1A1GLAPOLBLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10347846-B2 Organic compound for organic EL device and using the same LUMINESCENCE TECHNOLOGY CORP. (TW) 2019-07-09 — — US disclosed
US-20180166640-A1 ORGANIC COMPOUND FOR ORGANIC EL DEVICE AND USING THE SAME LUMINESCENCE TECHNOLOGY CORPORATION (TW) 2018-06-14 — — US disclosed
US-20180166640-A1 ORGANIC COMPOUND FOR ORGANIC EL DEVICE AND USING THE SAME LUMINESCENCE TECHNOLOGY CORPORATION (TW) 2018-06-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10347846-B2 Organic compound for organic EL device and using the same L1CAM, ESR1, XPO4 KDM4E 2116/4885HSD17B10 3649/4885AVPR1A 3019/4885
US-20180166640-A1 ORGANIC COMPOUND FOR ORGANIC EL DEVICE AND USING THE SAME L1CAM, ESR1, XPO4 KDM4E 2116/4885HSD17B10 3649/4885AVPR1A 3019/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback